Non-invasive actionable biomarkers for metastatic prostate cancer
In the current clinical setting, many disease management options are available for men diagnosed with prostate cancer. For metastatic prostate cancer, first-line therapies almost always involve agents designed to inhibit androgen receptor (AR) signaling. Castration-resistant prostate cancers (CRPCs)...
| Published in: | Asian Journal of Urology |
|---|---|
| Main Author: | |
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2016-10-01
|
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2214388216300637 |